XT
DSGN icon

XTX Topco’s Design Therapeutics DSGN Stock Holding History

XTX Topco’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$648K Buy
60,939
+25,655
+73% +$260K 0.01% 1786
2025
Q4 		$331K Buy
35,284
+23,416
+197% +$183K 0.01% 1978
2025
Q3 		$89.4K Buy
+11,868
New +$59.4K ﹤0.01% 2048
2025
Q1 		– Sell
-48,424
Closed -$299K – 2560
2024
Q4 		$299K Buy
+48,424
New +$280K 0.02% 1224
2024
Q2 		– Sell
-15,257
Closed -$61.5K – 2000
2024
Q1 		$61.5K Buy
+15,257
New +$40.7K 0.01% 1442
2023
Q4 		– Sell
-38,472
Closed -$90.8K – 1709
2023
Q3 		$90.8K Buy
38,472
+27,673
+256% +$129K 0.02% 1196
2023
Q2 		$68K Buy
+10,799
New +$66.1K 0.01% 1205

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

XTX Topco's DSGN Position: Q1 2026 in Review

XTX Topco increased its Design Therapeutics (DSGN) stake by 73% in Q1 2026, buying an estimated $260K and bringing the position to 60,939 shares worth $648K. The position accounts for 0.01% of the portfolio, ranked #1786.

XTX Topco first reported a position in DSGN in Q2 2023 and has held it in 7 quarters since. 125 funds tracked by Wall St. Rank hold DSGN as of Q1 2026.

  • XTX Topco held 60,939 shares of Design Therapeutics worth $648K as of Q1 2026.
  • XTX Topco bought 25,655 Design Therapeutics shares in Q1 2026, an estimated $260K.
  • Design Therapeutics made up 0.01% of XTX Topco's portfolio in Q1 2026, its #1786 holding.
  • XTX Topco first reported a position in Design Therapeutics in Q2 2023 and has held it in 7 quarters since.
  • 125 funds tracked by Wall St. Rank held Design Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.